| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d173508996911b655b3513437237bbcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aeb0187e5be044fbfd801ad131c6d70f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01d3459de945b669ade0ac6ce585c008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_54d6efd916a5e45bffc34934d001d394 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-413 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-361
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-86 |
| filingDate |
2007-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27a8a0de21b5906f7248fc3578b2f116
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_115e5f48b0e39cd073a451b376548b3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e21c5b0156abcc04814812e6d08d674 |
| publicationDate |
2007-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007104732-A2 |
| titleOfInvention |
Stable nanocapsule systems for the administration of active molecules |
| abstract |
The invention is aimed at nanocapsule systems characterized in that they have high stability during long periods of time. These systems are useful for the controlled release of pharmacologically or cosmetically active ingredients of highly lipophilic nature. The system comprises nanocapsules with an average size less than 1 μm dispersed in an aqueous medium, wherein the nanocapsules have a structure which comprises a lipophilic phase containing a phospholipid component and one or more saturated and/or unsaturated C12-C24 chain fatty acids or derivatives thereof; and a hydrophilic phase which comprises chitosan or a derivative thereof and a polyoxyalkylenated compound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010016686-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109316602-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2200588-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9974753-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012529458-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010016686-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102802616-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101199580-B1 |
| priorityDate |
2006-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |